Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

January 6, 2018

Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium

“Improving Clinical Trials to Deliver Better Treatments,” as featured in the Spring 2018 edition of “Progress, the research magazine of Parkinson’s UK”

New Collaboration Seeks to Speed Huntington’s Disease Drug Licensing

This article originally appeared on HDBuzz and is reprinted here under Creative Commons license. Critical Path Institute launches

April 25, 2016-April 26, 2016

Ninth Annual Patient-Reported Outcome Consortium Workshop

April 25 – 26, 2018 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 On April 25-26, 2018 the NINTH ANNU

May 10, 2018

Training on the Use of Technology to Collect Patient-Reported Outcome Data Electronically in Clinical Trials: Best Practice Recommendations from the ePRO Consortium (May 10, 2018)

This webinar provides a recommended framework for training end users, including site staff and study participants, on the use of e

C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)

TUCSON, Ariz. – May 7, 2018 — Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

April 28, 2018

Dr. Stephenson’s presentation at University of Texas Health, San Antonio, The Perry and Ruby Stevens Parkinson’s Disease Center of Excellence: “Critical Path for Parkinson’s Collaboration to Enable Patient Focused Drug Development and Precision Medicine”

CPTR Newsletter – April 2018

CPTR Newsletter – April 2018 In this issue: ReSeqTB to be Adopted for WHO Surveillance of Drug-Resistant TB New Collabora

Helmsley Charitable Trust Awards Critical Path Institute a Grant to Focus on Crohn’s Disease Biomarkers

Tucson, AZ, and New York, NY – April 16, 2018 — The Leona M. and Harry B. Helmsley Charitable Trust has awarded Critical Path

C-Path and CHDI launch consortium to accelerate development of Huntington’s disease therapies

Tucson, AZ, and New York, NY – March 28, 2018 – The Critical Path Institute (C-Path), together with CHDI Foun

Previous5960 61...109 Next